City of Hope receives $4.9M for stem cell training program

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

Researchers at City of Hope found that taking white button mushroom pills reduces a class of immune cells called myeloid-derived suppressor cells, which has been linked to cancer development and spread.

November 22, 2024

Vol.50 No.44

Clinical Roundup

Fralin Biomedical Research Institute spinoff company focuses on peptide drugs targeting cancer stem cells

Scientific progress often follows a prolonged path, but bioentrepreneur Samy Lamouille believes his dedication toward this pursuit will ultimately pay off for brain cancer patients.

November 22, 2024

Vol.50 No.44

Clinical Trials & Tribulations

How we improved the treatment of Hodgkin lymphoma

Hodgkin lymphoma has long been a model disease in the field of oncology—one of the first diseases we learned to cure with radiation and ultimately chemotherapy.

RAS-mutant leukemia stem cells behave differently from other leukemia stem cells

Research from the Icahn School of Medicine at Mount Sinai provides new insights into acute myeloid leukemia and its resistance to a common treatment. The study, published Oct. 30 in Nature, was led by Eirini Papapetrou, professor of oncological sciences at Icahn Mount Sinai. Acute myeloid leukemia is a devastating blood cancer that starts in...

November 08, 2024

Vol.50 No.42

In Brief

Longevity Consortium receives $45M grant

The Longevity Consortium received a five-year, $45 million grant to move the consortium’s work to its next stage: integrating results from numerous studies about the factors that contribute to longer and healthier lives.

November 01, 2024

Vol.50 No.41

In Brief

Robert Jenq named director of microbiome program at City of Hope

Robert R. Jenq was named director of the microbiome program at City of Hope and clinical professor in the Department of Hematology and Hematopoietic Cell Transplantation.

September 20, 2024

Vol.50 No.35

City of Hope receives $4.9M for stem cell training program

YOU MAY BE INTERESTED IN

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

Fralin Biomedical Research Institute spinoff company focuses on peptide drugs targeting cancer stem cells

How we improved the treatment of Hodgkin lymphoma

RAS-mutant leukemia stem cells behave differently from other leukemia stem cells

Longevity Consortium receives $45M grant

Robert Jenq named director of microbiome program at City of Hope

Renew today!

Subscriber content

Never miss an issue!

Login